Interne link ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference september 28, 2023 om 12:00 PM UTC
Interne link ProQR Therapeutics Provides Update on Ophthalmic Assets september 27, 2023 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference september 07, 2023 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2023 Operating and Financial Results augustus 03, 2023 om 11:00 AM UTC
Interne link ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets augustus 01, 2023 om 11:00 AM UTC
Interne link ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit juli 06, 2023 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2023 Operating and Financial Results mei 16, 2023 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 mei 09, 2023 om 12:00 PM UTC
Interne link ProQR Announces Upcoming Investor Conferences in April and May april 20, 2023 om 12:00 PM UTC
Interne link ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 april 18, 2023 om 12:00 PM UTC
Interne link ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event maart 29, 2023 om 12:00 PM UTC
Interne link ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing maart 14, 2023 om 12:00 PM UTC
Interne link ProQR to Present at Upcoming Scientific and Industry Conferences maart 07, 2023 om 01:00 PM UTC
Interne link ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 februari 28, 2023 om 01:00 PM UTC
Interne link ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform december 22, 2022 om 11:15 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 november 14, 2022 om 09:30 PM UTC
Interne link ProQR Announces Third Quarter 2022 Operating and Financial Results november 09, 2022 om 12:00 PM UTC
Interne link ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference november 03, 2022 om 11:00 AM UTC
Interne link ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs augustus 11, 2022 om 11:00 AM UTC
Interne link ProQR Announces Second Quarter 2022 Operating and Financial Results augustus 04, 2022 om 11:00 AM UTC
Interne link ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium juni 28, 2022 om 11:00 AM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates juni 01, 2022 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 mei 09, 2022 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2022 Operating and Financial Results mei 05, 2022 om 08:30 PM UTC